We just received data on a new analyst forecast for $IMRX. Geulah Livshits from Chardan Capital set a price target of 20.0 for IMRX.
To track analyst ratings and price targets for $IMRX, check out Quiver Quantitative's $IMRX forecast page.
Should you buy $IMRX?
Some analysts are better than others. To view the past performance of Chardan Capital, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$IMRX Price Targets
Multiple analysts have issued price targets for $IMRX recently. We have seen 2 analysts offer price targets for $IMRX in the last 6 months, with a median target of $15.5.
Here are some recent targets:
- Geulah Livshits from Chardan Capital set a target price of $20.0 on 05/19/2026
- Ami Fadia from Needham set a target price of $11.0 on 03/09/2026
$IMRX Insider Trading Activity
$IMRX insiders have traded $IMRX stock on the open market 5 times in the past 6 months. Of those trades, 5 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $IMRX stock by insiders over the last 6 months:
- THOMAS J. SCHALL purchased 21,645 shares for an estimated $101,041
- PETER FEINBERG purchased 20,000 shares for an estimated $86,904
- HAROLD EUGENE BRAKEWOOD (Chief Business Officer) purchased 5,250 shares for an estimated $24,990
- LEAH R NEUFELD (CHIEF PEOPLE OFFICER) purchased 2,626 shares for an estimated $10,905
- BRETT MATTHEW HALL (CHIEF SCIENTIFIC OFFICER) purchased 2,298 shares for an estimated $10,501
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$IMRX Hedge Fund Activity
We have seen 58 institutional investors add shares of $IMRX stock to their portfolio, and 50 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- EMPERY ASSET MANAGEMENT, LP added 2,674,950 shares (+inf%) to their portfolio in Q4 2025, for an estimated $17,601,171
- STATE STREET CORP removed 2,133,718 shares (-88.8%) from their portfolio in Q1 2026, for an estimated $11,244,693
- EXODUSPOINT CAPITAL MANAGEMENT, LP removed 1,516,833 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $9,980,761
- MARSHALL WACE, LLP added 1,284,710 shares (+180.5%) to their portfolio in Q1 2026, for an estimated $6,770,421
- MILLENNIUM MANAGEMENT LLC added 1,051,789 shares (+2065.4%) to their portfolio in Q1 2026, for an estimated $5,542,928
- LOGOS GLOBAL MANAGEMENT LP removed 950,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $6,251,000
- BLUE OWL CAPITAL HOLDINGS LP removed 665,000 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $3,504,549
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
